中梁控股(2772.HK)首日上市一度大涨11.36%市值逼近220亿
格隆汇7月16日丨中梁控股(2772.HK)今日首日上市,正式成为港股内房股中的一员,盘中一度大涨11.36%至6.18港元,市值最高达218亿港元。现报6.05港元,涨9.01%,暂成交2.27亿港元,最新总市值213.56亿港元。

本次中梁最终发行定价为5.55港元,募资净额27.7亿港元。
据悉,中梁控股算是近年房企发展的“优等生”,其发轫于温州,目前将总部设立在上海,长期深耕长三角区域,布局全国。
据亿翰智库,2019年中梁控股被评为前20强中国房地产开发企业。2018年中梁全年销售金额成功突破千亿,全口径销售金额达1015亿,近三年销售额年复合增长率达131%。分析人士称,其快速增长主要得益与踩准中国房地产行业的发展周期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.